Company Amoy Diagnostics Co., Ltd.

Stocks

300685

CNE1000034D3

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 15/07/2026			5-day change	1st Jan Change
18.57 ^CNY	+3.69%		+7.90%	-9.24%

07-02	Tranche Update on Amoy Diagnostics Co., Ltd.'s Equity Buyback Plan announced on October 24, 2025.	CI
06-05	Sinopharm Group Science and Technology Innovation Research Institute Co., Ltd. entered into agreement to acquire 20% stake in Amoy Diagnostics Co., Ltd. from Foresight Investment (Hong Kong) Limited for CNY 1.7 billion.	CI

Business description: Amoy Diagnostics Co., Ltd.

Amoy Diagnostics Co Ltd is a China-based company mainly providing tumor gene testing services. The Company mainly operates three businesses. The testing reagent business is engaged in the research, development and production of reagents such as gene mutation detection kits, human microsatellite instability (MSI) detection kits, human B-Raf proto-oncogene (BRAF) V600E mutation detection kits and estrogen receptor antibody reagents. The testing services business mainly provides medical testing services to pharmaceutical companies and research institutions. The drug clinical research services business mainly provides central laboratory testing and companion diagnostic registration services to pharmaceutical companies. The Company is also engaged in the research, development and production of human 12-gene mutation analysis software, as well as supporting instruments such as gene sequencers, fully automated nucleic acid extractors and fully automated immunohistochemical staining machines.

Number of employees: 1,175

Sales by Activity: Amoy Diagnostics Co., Ltd.

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Detection Reagent	699M	611M	860M	877M	952M
Drug Clinical Research Services	54.18M	86.04M	88.71M	161M	158M
Testing Service	155M	135M	84.94M	66.56M	77.31M
Unallocated Other Operations	8.91M	9.75M	9.99M	4.64M	10.39M

See all business segments

Geographical breakdown of sales: Amoy Diagnostics Co., Ltd.

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
China	812M	697M	847M	849M	926M
Overseas	105M	145M	196M	260M	272M

See all geographic segments

Executive Committee: Amoy Diagnostics Co., Ltd.

Manager	Title	Age	Since
Jie Min Luo CEO	Chief Executive Officer	43	30/11/2021
Ying Chen DFI	Director of Finance/CFO	56	17/06/2015
Frank Ron Zheng PRN	Corporate Officer/Principal	36	07/01/2025
Li Ruan CTO	Chief Tech/Sci/R&D Officer	48	31/07/2008
Shou Gan Yang IRC	Investor Relations Contact	-	-

See AMOY DIAGNOSTICS CO., LTD. governance

Composition of the Board of Directors: Amoy Diagnostics Co., Ltd.

Director	Title	Age	Since
Li Mou Zheng CHM	Chairman	73	20/02/2008
Jie Min Luo BRD	Director/Board Member	43	12/08/2021
Frank Ron Zheng BRD	Director/Board Member	36	12/08/2021
En Hua Wang BRD	Director/Board Member	71	29/09/2021
Li Ruan BRD	Director/Board Member	48	27/02/2023
Qiao Wu BRD	Director/Board Member	67	13/08/2024
Zhe Shen BRD	Director/Board Member	48	17/05/2023

Composition of the Board of Directors

Shareholders: Amoy Diagnostics Co., Ltd.

Name	Stocks	%	Valuation
Li Mou Zheng 22.06 %	87,701,616	22.06 %	218 M ¥
Xiamen Yixiang Investment Partnership LP 5.038 %	20,026,900	5.038 %	50 M ¥
Xiao Li Qiu 4.944 %	19,653,046	4.944 %	49 M ¥
Xiamen Haicang Rundingsheng Investment LP 1.371 %	5,448,726	1.371 %	14 M ¥
Basic Pension Fund 161032 Combination 1.132 %	4,500,056	1.132 %	11 M ¥

Name	Stocks	%	Valuation
Li Ruan 21.52 %	114,806	21.52 %	284 926 ¥
Guan Shan Zhu 21.35 %	113,906	21.35 %	282 692 ¥
Jie Min Luo 21.35 %	113,906	21.35 %	282 692 ¥
Hui Bin Zheng 21.35 %	113,906	21.35 %	282 692 ¥
Ying Chen 21.35 %	113,906	21.35 %	282 692 ¥

List of AMOY DIAGNOSTICS CO., LTD. shareholders

Company details: Amoy Diagnostics Co., Ltd.

Amoy Diagnostics Co., Ltd.

39 Dingshan Road

361027, Xiamen

http://www.amoydx.com

address Amoy Diagnostics Co., Ltd.(300685)

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOY DIAGNOSTICS CO., LTD.	+3.69%	+7.90%	-18.70%	-21.91%	1.02B
GUARDANT HEALTH, INC.	+1.78%	+0.02%	+227.43%	+325.26%	21.23B
BIOMÉRIEUX	+2.35%	+1.84%	-39.92%	-23.52%	9.48B
LANTHEUS HOLDINGS, INC.	+1.90%	+0.88%	+25.60%	+21.18%	6.66B
10X GENOMICS, INC.	-0.09%	+20.94%	+266.88%	-21.26%	5.81B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.87%	+11.36%	-19.82%	-30.48%	5.05B
CARIS LIFE SCIENCES, INC.	+3.01%	-0.06%	-37.01%	-	4.79B
DIASORIN S.P.A.	-0.32%	+3.67%	-23.27%	-25.95%	4.23B
ANDON HEALTH CO., LTD.	+10.00%	+12.12%	+81.10%	+93.89%	3.77B
AUTOBIO DIAGNOSTICS CO., LTD.	+1.85%	+6.43%	-14.58%	-40.20%	2.69B
Average	+2.50%	+5.39%	+44.77%	+30.78%	6.47B
Weighted average by Cap.	+2.10%	+2.81%	+93.37%	+111.11%